iXCells Biotechnologies

Headquartered in San Diego, CA, iXCells Biotechnologies is a leading cell biology and cell technology company specializing in preclinical drug discovery solutions with focus on disease relevant cellular models enabling technologies and services to the academic, biotech and pharma communities. iXCells provides high quality primary cells normal and diseased iPS cell lines, iPSC-derived cell products, custom iPSC services, functional bioassay development and execution, among other products and services

Induced pluripotent stem cells,primary cells,genome editing,cell-based bioassays,organotypic culture models,patient-derived ipsc generation,drug discovery,disease-in-a-dish,cellular model,immuno-oncology,immunoassays,preclinical cro services,orphan disease,personalized medicine,ipsc,rare disease,patient-specific cells,aso screening,and antisense oligonucleotides

Ixcells biotechnologies operates in the Biotechnology research industry.

Ixcells biotechnologies's revenue is 1m - 10m

Ixcells biotechnologies has 11 - 50 employees.